Literature DB >> 22619192

Bisphosphonates in the treatment of osteoporosis.

Kenneth E Poole1, Juliet E Compston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22619192     DOI: 10.1136/bmj.e3211

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.

Authors:  Jennifer M Bell; Michael D Shields; Janet Watters; Alistair Hamilton; Timothy Beringer; Mark Elliott; Rosaline Quinlivan; Sandya Tirupathi; Bronagh Blackwood
Journal:  Cochrane Database Syst Rev       Date:  2017-01-24

2.  Smart, programmable and responsive injectable hydrogels for controlled release of cargo osteoporosis drugs.

Authors:  Konstantinos E Papathanasiou; Petri Turhanen; Stephan I Brückner; Eike Brunner; Konstantinos D Demadis
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

3.  Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication-Survey among physicians and lay persons in Germany.

Authors:  Piet van der Keylen; Nikoletta Zeschick; Anna Ruth Schlenz; Thomas Kühlein
Journal:  PLoS One       Date:  2022-08-11       Impact factor: 3.752

4.  Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study.

Authors:  M A Paggiosi; N Peel; E McCloskey; J S Walsh; R Eastell
Journal:  Osteoporos Int       Date:  2014-07-30       Impact factor: 4.507

5.  Do Bisphosphonate-related Atypical Femoral Fractures and Osteonecrosis of the Jaw Affect the Same Group of Patients? A Pilot Study.

Authors:  Haitham Afif; Sebastian Mukka; Göran Sjödén; Arkan S Sayed-Noor
Journal:  Orthop Rev (Pavia)       Date:  2014-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.